Valuation: Circio Holding ASA

Market Cap 3.68B 395M 342M 322M 292M 545M 37.72B 553M 3.84B 1.48B 19.2B 1.48B 1.45B 60.63B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 3.68B 395M 342M 322M 293M 545M 37.74B 553M 3.85B 1.48B 19.21B 1.48B 1.45B 60.67B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -
1 day+5.02%
1 week+3.55%
Current month+3.72%
1 month+46.77%
3 months+64.22%
6 months+152.83%
Current year+1,051.20%
1 week 12.28
Extreme 12.28
13.8
1 month 8.34
Extreme 8.34
15.7
Current year 0.98
Extreme 0.978
15.7
1 year 0.58
Extreme 0.584999
15.7
3 years 0.48
Extreme 0.48
15.7
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
11/30/21 A Exercice

Chief Executive Officer

120,000 0.1386%
5/19/21 A Buy

Director

21,299 0.0246%
12/3/20 A Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+5.02%+3.55%+2,096.72%+18.32% 377M
+5.04%+3.27%+50.62%+105.43% 66.93B
+1.64%-2.89%+34.67%+80.49% 61.97B
-3.18%-0.78%-14.14%+376.43% 28.26B
+4.55%-0.08%+34.70%+17.28% 24.59B
+2.20%-4.72%+2.19%-12.71% 24.3B
+1.15%-2.26%+17.56%-16.53% 19.41B
-7.03%-9.16%+161.91%+303.00% 16.77B
+3.44%-1.68%-5.00%+541.17% 14.18B
+4.96%+4.63%-2.75%+879.79% 14B
Average +1.78%-3.69%+237.65%+229.27% 27.08B
Weighted average by Cap. +1.99%-2.84%+36.12%+175.62%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.17M 5.34M 5.04M 4.57M 8.51M 590M 8.64M 60.1M 23.17M 300M 23.17M 22.66M 948M -45.91M -4.92M -4.26M -4.02M -3.65M -6.79M -471M -6.9M -47.96M -18.49M -239M -18.49M -18.08M -756M
Net Debt -972K -104K -90.25K -85.12K -77.22K -144K -9.96M -146K -1.02M -391K -5.07M -392K -383K -16.01M 2.24M 241K 208K 197K 178K 332K 23.01M 337K 2.35M 904K 11.71M 904K 884K 36.99M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
11
Date Price Change Volume
14/09/26 NOK 13.40 +5.02% 7,403,101
11/09/26 NOK 12.76 -1.39% 3,271,926
10/09/26 NOK 12.94 -0.31% 6,260,067
09/09/26 NOK 12.98 -2.55% 2,983,578
08/09/26 NOK 13.32 +0.60% 10,294,871

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!